Watch full volume video:
The death this week of a musician who said he was denied a liver transfer because of his medical-marijuana use has highlighted a new ethical consideration: Should pot conversion to any act with a doctor’s blessing be held over against a dying patient who necessarily an organ transplant?
Timothy Garon, 56, used marijuana to ease the symptoms of advanced hepatitis C. Dr. Brad Roter, the physician who authorized Garon to smoke pot to lessen nausea and abdominal pain and to stimulate his appetite
Garon died Thursday, one week after he said he learned from his doctor that a University of Washington Medical Center committee had again denied him a spot on the liver-transplant listel.
“He said I’m going to die, by so conviction,” Garon said then. “I’m not angry, I’m not lunatic, I’m just confused.”
His death at Bailey-Boushay House, an intensive-care nursing center, was confirmed Friday by means of his lawyer, Douglas Hiatt, and Alisha Mark, a spokeswoman for Virginia Mason Medical Center, which operates Bailey-Boushay.
Garon, lead singer as far as concerns Nearly Dan, a Steely Dan cover band, believed he contracted hepatitis by sharing needles through “speed freaks” as a teenager. In recent years, he said, pot had been the only mix with drugs he’d used. In December, he was arrested for growing marijuana.
The UW Medical Center declined to confer about Garon’s case specifically, but released a statement saying: “Although sanatory marijuana may be an issue in rare cases, it is the sole determinant in arriving at medical decisions about candidates for organ transplants, and whether a patient is listed. Patients with a reasonable chance of survival and a good outcome, given a variety of factors, are listed.”
The statement also noted that there are about 98,000 patients waiting for organs in the United States and only 6,000 donors available.
Hiatt said Friday that UW was being “completely disingenuous” about the carry denial: “They denied him for the cause that of medical-marijuana use,” he said. “They gain a shortage of organs, and they’re using moral judgments to decide who gets any.”
Garon had been in the hospice for brace months. His savant at Harborview Medical Center told him she wouldn’t put in his paperwork for transplant cause at UW until he avoided pot on this account that six months, Hiatt said. The university soon offered to reconsider if he enrolled in a 60-day drug-treatment program, but his liver disease was too advanced by then for him to last that long, doctors told him. The university-hospital committee agreed to reconsider its settlement, then denied him once more.
Because of the scarcity of donated organs, plant in a new place committees like as the one at the UW Medical Center be beneath the necessity tough standards for deciding who should get them. Does a candidate have other serious health problems? Will he or she religiously take anti-rejection medicines? Is in that place good family support? Is the candidate probable to drink or do drugs? And what about therapeutical marijuana authorized by a doctor?
“Most transplant centers struggle with issues of how to deal with clan who are known to practice marijuana, whether or not it’s by a doctor’s prescription,” said Dr. Robert Sade, director of the Institute of Human Values in Health Care at the Medical University of South Carolina. “Marijuana, unlike alcohol, has none direct force on the liver. It is, but, a make uneasy … in that it’s a potential indicator of an addictive personality.”
Garon’s girlfriend, Leisa Bueno, of Olympia, said Garon had not used other drugs or alcohol since he was diagnosed with hepatitis in 2001.
The Virginia-based United Network for Organ Sharing, which oversees the commonwealth’s transpose system, leaves it to individual hospitals to develop criteria for transplant candidates. At some, people who application “illicit substances”
At others, such as the UCLA Medical Center, patients are given a jeopardy to reapply if they stay clean for six months. Marijuana use is unlicensed under founded on law.
Typically, doctors don’t realize that authorizing marijuana use for nausea or other disease complications may jeopardize their assiduous’s chance for a transplant, said Peggy Stewart, a clinical social handicraftsman on the liver-transplant team at UCLA who has researched the issue.
“There needs to be some kind of general eligibility criteria so that everyone will discern what the rules are,” Stewart said.
The patients “are trusting their physician to do the not crooked thing. The physician prescribes marijuana, they take the marijuana, and they are shocked that this is now the extremity result.”
No any tracks in what way multitude patients are denied transplants over medical-marijuana use. Pro-marijuana groups have cited a maniple of cases, including at least sum of two units patient deaths, in Oregon and California, since the mid- to late 1990s, when states began adopting medical-marijuana laws.
Another Seattle-area patient, Jonathan Simchen, 33, of Fife, Pierce County, said he was rejected as a kidney-transplant candidate at Virginia Mason and told through the UW that he will not be listed until he abstains from pot for six months.
Simchen said he uses marijuana to control his blood pressure and to stimulate his appetite, which is disrupted by dialysis.
Many doctors agree that using marijuana